389 related articles for article (PubMed ID: 25320535)
1. Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.
Zhang WZ; Chen JZ; Li DR; Chen ZJ; Guo H; Zhuang TT; Li DS; Zhou MZ; Chen CZ
World J Gastroenterol; 2014 Oct; 20(38):13973-80. PubMed ID: 25320535
[TBL] [Abstract][Full Text] [Related]
2. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of 3DCRT and IMRT in radical chemoradiotherapy of squamous cell carcinoma esophagus.
Krishnapriya P; Sivanandan CD; Roshni S; Sarin B; Geethi MH; Jagathnath Krishna KM
J Cancer Res Ther; 2023 Oct; 19(7):1844-1851. PubMed ID: 38376288
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.
Li XL; Chen ZY; Cui YC; Sheng XG
Int J Gynecol Cancer; 2015 Jun; 25(5):903-9. PubMed ID: 25822099
[TBL] [Abstract][Full Text] [Related]
5. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer.
Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M
J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871
[TBL] [Abstract][Full Text] [Related]
6. Impact of gastric filling on radiation dose delivered to gastroesophageal junction tumors.
Bouchard M; McAleer MF; Starkschall G
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):292-300. PubMed ID: 20092963
[TBL] [Abstract][Full Text] [Related]
7. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?
Zhou J; Fei D; Wu Q
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):673-82. PubMed ID: 14529771
[TBL] [Abstract][Full Text] [Related]
8. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
10.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
11. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cerebral malignant gliomas.
Zheng R; Fan R; Wen H; Luo J; Yang Y
J BUON; 2015; 20(1):248-52. PubMed ID: 25778324
[TBL] [Abstract][Full Text] [Related]
13. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
[TBL] [Abstract][Full Text] [Related]
14. Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?
Mayinger M; Borm KJ; Dreher C; Dapper H; Duma MN; Oechsner M; Kampfer S; Combs SE; Habermehl D
Radiat Oncol; 2019 Aug; 14(1):135. PubMed ID: 31370876
[TBL] [Abstract][Full Text] [Related]
15. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
[TBL] [Abstract][Full Text] [Related]
17. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
18. DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer.
Münch S; Oechsner M; Combs SE; Habermehl D
Radiat Oncol; 2017 Aug; 12(1):128. PubMed ID: 28806990
[TBL] [Abstract][Full Text] [Related]
19. Comparing treatment plan in all locations of esophageal cancer: volumetric modulated arc therapy versus intensity-modulated radiotherapy.
Lin JC; Tsai JT; Chang CC; Jen YM; Li MH; Liu WH
Medicine (Baltimore); 2015 May; 94(17):e750. PubMed ID: 25929910
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.
Zhang Y; Wang H; Huang X; Zhang Q; Ren R; Sun R; Zheng Z; Dong S; Zheng A
Med Dosim; 2019 Summer; 44(2):167-172. PubMed ID: 29950277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
